Novel Strategies for Reducing Burn Scar Itch
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThe University of Texas Medical Branch, Galveston
About this trial
The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.
Eligibility criteria
Qualifiers
Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures.
Adults: ≥18 to <80 years of age.
Has an itchy burn scar.
Disqualifiers
Failure to obtain consent or unable to return for follow up assessments.
Patient is unable to follow the protocol required assessments.
Member of a vulnerable class (e.g., prisoners, pregnant participant, etc.).
Any medical condition that, in the opinion of the investigator or physician, would place the participant at increased risk for participation.
Trial design
Treatments tested in this trial
- Famotidine and 4% topical cromolyn sodium
- Placebo
Treatment groups
44 Participants
are divided into 2 treatment groupsSponsors and collaborators
The University of Texas Medical Branch, Galveston
Lead sponsor
University of Texas
Collaborator
Source ClinicalTrials.gov